Does BASILIXIMAB Cause Focal segmental glomerulosclerosis? 67 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Focal segmental glomerulosclerosis have been filed in association with BASILIXIMAB (Simulect). This represents 1.0% of all adverse event reports for BASILIXIMAB.
67
Reports of Focal segmental glomerulosclerosis with BASILIXIMAB
1.0%
of all BASILIXIMAB reports
3
Deaths
36
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From BASILIXIMAB?
Of the 67 reports, 3 (4.5%) resulted in death, 36 (53.7%) required hospitalization, and 4 (6.0%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BASILIXIMAB. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does BASILIXIMAB Cause?
Cytomegalovirus infection (590)
Drug ineffective (567)
Off label use (567)
Transplant rejection (554)
Kidney transplant rejection (456)
Product use in unapproved indication (428)
Pyrexia (323)
Diarrhoea (314)
Multiple organ dysfunction syndrome (298)
Polyomavirus-associated nephropathy (298)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
MYCOPHENOLIC ACID (55)
Which BASILIXIMAB Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
BASILIXIMAB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BASILIXIMAB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED
BASILIXIMAB vs BCG VACCINE
BASILIXIMAB vs BEBTELOVIMAB
BASILIXIMAB vs BECLOMETHASONE